MedTrace Logo

Metabolic Disorders and Vertigo

NCT04935970 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-06-23

No results posted yet for this study

Summary

The purpose of investigation is to assess the levels of metabolic factors (hydroxyvitamin D, homocysteine) between patients with vestibular dysfunction of peripheral origin (BPPV) and central origin (vestibular migraine). Also we will analyse another factors (such as anxiety and depression) and optimize therapeuthical approach accordingly with the data.

Conditions

  • Benign Paroxysmal Positional Vertigo (BPPV)
  • Vestibular Migraine
  • Central Positional Vertigo
  • Vestibular Neuritis
  • Meniere Disease

Interventions

DIAGNOSTIC_TEST

diagnostic blood test

vitamin D deficiency/insufficiency reveal, hyperhomocysteinaemia reveal

DIAGNOSTIC_TEST

neuropsychological test

neuropsychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'scale.

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Anna Bedenko, PhD student · I.M. Sechenov First Moscow State Medical University (Sechenov University)

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-10
Primary Completion
2021-12-30
Completion
2022-08-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04935970 on ClinicalTrials.gov